After 28 days of treatment, BL1107 did not meet its main goal of improving visual field scores in a study.

July 9 (Reuters) - Bausch + Lomb said on Thursday its glaucoma eye drop had missed the main goal in a mid-stage trial of ...

Supplementation with vitamin B3 is associated with a 66% lower risk of developing glaucoma in people with high eye pressure, a real-world study shows.

Bausch + Lomb will stop developing a topical eye drop for glaucoma after the drug failed to meet its primary endpoint in a phase 2 study. The company on Thursday said the drug, BL1107, didn't ...

Bausch + Lomb (BLCO) is in focus after two product updates: a discontinued glaucoma eye drop program for BL1107 and the ...

Thank you for signing up! Did you know with a Digital Subscription to The Scotsman, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, ...

Glaucoma impacts the vision of more than 3 million Americans, increasing the pressure in the eye, damaging the optic nerve and, if left untreated, causing permanent damage and vision loss. Until now, ...

Glaucoma is one of the three leading causes of blindness in Germany and worldwide. This neurodegenerative disease progressively damages the retinal nerve fibres, leading to irreversible vision loss.

Bausch + Lomb has abandoned its next great hope in glaucoma after the eye drops flunked a phase 2 study. The eye health company had been evaluating the alpha-2B agonist, dubbed BL1107, in a mid-stage ...

Using pilocarpine eye drops following Kahook Dual Blade (KDB) goniotomy surgery may improve clinical outcomes for patients with glaucoma and reduce the need for future medications, according to new ...

Please provide your email address to receive an email when new articles are posted on . Interventional procedures with eye drops as an adjunct are slowly becoming the foundational therapy for glaucoma ...

The CDC reports that over three million Americans have glaucoma. The number may reach 6.3 million by 2050 as the aging population grows. Glaucoma is affecting so many lives, so it’s important to know ...